Overview

Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects

Status:
Recruiting

Trial end date:
2021-09-01

Target enrollment:

Participant gender:

Summary

Phase 1, single-center (United Kingdom), open-label, nonrandomized, single-dose study in healthy adult male subjects to assess the absorption, metabolism, and excretion of [14C]-Ecopipam in Healthy Male Subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Emalex Biosciences Inc.

Collaborator:

Covance

Treatments:

Ecopipam